Ditchcarbon
  • Contact
  1. Organizations
  2. ISU Abxis Co., Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
KR
updated 2 months ago

ISU Abxis Co., Ltd. Sustainability Profile

Company website

ISU Abxis Co., Ltd., a prominent player in the biotechnology sector, is headquartered in South Korea (KR) and operates extensively across Asia and beyond. Founded in 2004, the company has established itself as a leader in the development of innovative diagnostic solutions and therapeutic antibodies, catering to the growing demands of the healthcare industry. ISU Abxis is renowned for its cutting-edge products, including monoclonal antibodies and diagnostic kits, which are distinguished by their high specificity and reliability. The company’s commitment to research and development has led to significant advancements in immunology and molecular diagnostics, positioning it as a trusted partner in the global market. With a focus on quality and innovation, ISU Abxis continues to achieve notable milestones, solidifying its reputation as a key contributor to the biotechnology landscape.

DitchCarbon Score

How does ISU Abxis Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

ISU Abxis Co., Ltd.'s score of 20 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Let us know if this data was useful to you

ISU Abxis Co., Ltd.'s reported carbon emissions

ISU Abxis Co., Ltd., headquartered in South Korea (KR), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that ISU Abxis may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company does not inherit any emissions data or targets from a parent or related organization, indicating a standalone approach to its environmental impact.

How Carbon Intensive is ISU Abxis Co., Ltd.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ISU Abxis Co., Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is ISU Abxis Co., Ltd.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ISU Abxis Co., Ltd. is in KR, which we do not have grid emissions data for.

ISU Abxis Co., Ltd.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

ISU Abxis Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare ISU Abxis Co., Ltd.'s Emissions with Industry Peers

Actelion Pharmaceuticals Ltd

CH
•
Research and development services (73)
Updated 16 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Actelion Ltd

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Genzyme Corporation, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251118.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy